232 related articles for article (PubMed ID: 27955710)
1. Quantitative evaluation of essential medicines lists: the South African case study.
Perumal-Pillay VA; Suleman F
BMC Health Serv Res; 2016 Dec; 16(1):687. PubMed ID: 27955710
[TBL] [Abstract][Full Text] [Related]
2. Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members.
Perumal-Pillay VA; Suleman F
BMC Health Serv Res; 2017 Jan; 17(1):17. PubMed ID: 28061899
[TBL] [Abstract][Full Text] [Related]
3. Essential medicines lists for children of WHO, India, South Africa, and EML of China: A comparative study.
Liu D; Cheng J; Zhang LL; Li YP; Zeng LN; Zhang C; Gui G
J Evid Based Med; 2017 Nov; 10(4):271-280. PubMed ID: 28276634
[TBL] [Abstract][Full Text] [Related]
4. GRADE Concept 7: Issues and Insights Linking Guideline Recommendations to Trustworthy Essential Medicine Lists.
Piggott T; Moja L; Jenei K; Kredo T; Skoetz N; Banzi R; Trapani D; Leong T; McCaul M; Lavis JN; Akl EA; Nonino F; Iorio A; Laurson-Doube J; Huttner BD; Schünemann HJ
J Clin Epidemiol; 2024 Feb; 166():111241. PubMed ID: 38123105
[TBL] [Abstract][Full Text] [Related]
5. Insights from the WHO and National Lists of Essential Medicines: Focus on Pediatric Diabetes Care in Africa.
Rowlands A; Ameyaw E; Rutagarama F; Dipesalema J; Majaliwa ES; Mbogo J; Ogle GD; Chanoine JP
Horm Res Paediatr; 2018; 90(2):82-92. PubMed ID: 30048982
[TBL] [Abstract][Full Text] [Related]
6. Decision criteria for selecting essential medicines and their connection to guidelines: an interpretive descriptive qualitative interview study.
Piggott T; Moja L; Akl EA; Lavis JN; Cooke G; Kredo T; Hogerzeil HV; Huttner B; Alonso-Coello P; Schünemann H
J Clin Epidemiol; 2023 Feb; 154():146-155. PubMed ID: 36584732
[TBL] [Abstract][Full Text] [Related]
7. Essential medicines for emergency care in Africa.
Broccoli MC; Pigoga JL; Nyirenda M; Wallis L; Calvello Hynes EJ
Emerg Med J; 2018 Jul; 35(7):412-419. PubMed ID: 29627770
[TBL] [Abstract][Full Text] [Related]
8. Audit of essential medicine listing and registration status of medicines on standard treatment guidelines in Kenya, Tanzania and Uganda: Case study of malaria, tuberculosis, hypertension and type 2 diabetes mellitus.
Babatunde D; Pollock AM; Ocan M; Brhlikova P
JRSM Open; 2024 Mar; 15(3):20542704241232814. PubMed ID: 38560365
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the implementation of the standard treatment guidelines (STGs) and essential medicines list (EML) at a public South African tertiary institution and its associated primary health care (PHC) facilities.
Govender T; Suleman F; Perumal-Pillay VA
J Pharm Policy Pract; 2021 Dec; 14(1):105. PubMed ID: 34906236
[TBL] [Abstract][Full Text] [Related]
10. A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list.
Naicker I; Suleman F; Perumal-Pillay VA
J Pharm Policy Pract; 2022 Dec; 15(1):97. PubMed ID: 36482421
[TBL] [Abstract][Full Text] [Related]
11. Essential cancer medicines in the national lists of countries of the WHO South-East Asia Region: a descriptive assessment.
Chivukula MV; Tisocki K
WHO South East Asia J Public Health; 2018 Sep; 7(2):90-98. PubMed ID: 30136667
[TBL] [Abstract][Full Text] [Related]
12. Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists.
Jarvis JD; Woods H; Bali A; Oronsaye E; Persaud N
PLoS One; 2019; 14(8):e0220781. PubMed ID: 31398195
[TBL] [Abstract][Full Text] [Related]
13. WHO and national lists of essential medicines in Mexico, Central and South America, and the Caribbean: are they adequate to promote paediatric endocrinology and diabetes care?
Rowlands A; Acosta-Gualandri A; Guevara-Aguirre J; Chanoine JP
BMJ Glob Health; 2016; 1(3):e000114. PubMed ID: 28588968
[TBL] [Abstract][Full Text] [Related]
14. The interpretation of China national essential medicines list 2018.
Zuo W; Mei D; Sun W; Tang X; Niu Z; Gao D; Zhang B
Expert Rev Clin Pharmacol; 2020 Feb; 13(2):191-200. PubMed ID: 31914825
[No Abstract] [Full Text] [Related]
15. Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO.
Piggott T; Nowak A; Brignardello-Petersen R; Cooke GS; Huttner B; Schünemann HJ; Persaud N; Magrini N; Moja L
BMJ Open; 2022 Feb; 12(2):e053349. PubMed ID: 35144950
[TBL] [Abstract][Full Text] [Related]
16. Essential Medicines List Implementation Dynamics: A Case Study Using Brazilian Federal Medicines Expenditures.
Magarinos-Torres R; Lynd LD; Luz TCB; Marques PEPC; Osorio-de-Castro CGS
Basic Clin Pharmacol Toxicol; 2017 Sep; 121(3):181-188. PubMed ID: 28371342
[TBL] [Abstract][Full Text] [Related]
17. Relation between opioid consumption and inclusion of opioids in 137 national essential medicines lists.
Richards GC; Aronson JK; Heneghan C; Mahtani KR; Koshiaris C; Persaud N
BMJ Glob Health; 2020 Nov; 5(11):. PubMed ID: 33173012
[TBL] [Abstract][Full Text] [Related]
18. Essential medicines for children in Armenia.
Kazaryan I; Vardanyan L
Int J Risk Saf Med; 2015; 27 Suppl 1():S43-4. PubMed ID: 26639704
[TBL] [Abstract][Full Text] [Related]
19. Drawing lessons from the standard treatment guidelines and essential medicines list concept in South Africa as the country moves towards national health insurance.
Perumal-Pillay VA; Suleman F
S Afr Fam Pract (2004); 2021 Jan; 63(1):e1-e3. PubMed ID: 33567840
[TBL] [Abstract][Full Text] [Related]
20. Use of evidence and negotiation in the review of national standard treatment guidelines and essential medicines list: experience from Ghana.
Koduah A; Asare BA; Gavor E; Gyansa-Lutterodt M; Andrews Annan E; Ofei FW
Health Policy Plan; 2019 Nov; 34(Supplement_2):ii104-ii120. PubMed ID: 31723963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]